IP Library Patent Application 16255347
Patent Application
App. No. 16/255,347

Generation of pancreatic endoderm from pluripotent stem cells using small molecules

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/255,347
Abstract

A method of producing pancreatic cells or pancreatic cell precursors expressing at least 5% PDX1/NKX6.1 double positive, comprising exposing definitive endoderm cells to an effective amount of one or more small molecules, to differentiate the human definitive endoderm cells into the pancreatic cells or pancreatic cell precursors. The present invention also relates to pancreatic endoderm cells produced by said methods and uses of said pancreatic endoderm cells.

Claims (5)

1 . A cell culture medium comprising definitive endoderm cells, a BMP inhibitor, JNK inhibitor II, bFGF, and a retinoic acid receptor agonist.

2 . The cell culture medium of claim 1 , wherein the BMP inhibitor is

3 . The cell culture medium of claim 1 , wherein the retinoic acid receptor agonist is

4 . The cell culture medium of claim 1 , wherein the BMP inhibitor is

and the retinoic acid receptor agonist is

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2026
From: NOVO NORDISK A/S
To: ASPECT BIOSYSTEMS LTD.
Reel/Frame 075363/0935 →
MERGER Recorded Dec 8, 2023
From: TAKARA BIO EUROPE AB
To: TAKARA BIO EUROPE SAS
Reel/Frame 065806/0224 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2022
From: NOVO NORDISK A/S
To: TAKARA BIO EUROPE AB
Reel/Frame 059830/0857 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2022
From: NOVO NORDISK A/S
To: NOVO NORDISK A/S; TAKARA BIO EUROPE AB
Reel/Frame 059770/0230 →